TY - JOUR
T1 - Disparities in characteristics, access to care, and oncologic outcomes in young-onset colorectal cancer at a safety-net hospital
AU - Fangman, Benjamin D.
AU - Goksu, Suleyman Y.
AU - Chowattukunnel, Nivan
AU - Beg, Muhammad S.
AU - Sanford, Nina N.
AU - Sanjeevaiah, Aravind
AU - Cox, John
AU - Folkert, Michael R.
AU - Aguilera, Todd A.
AU - Mathews, Joselin
AU - Pogacnik, Javier Salgado
AU - Khatri, Gaurav
AU - Olson, Craig
AU - Polanco, Patricio M.
AU - Verma, Udit
AU - Hsiehchen, David
AU - Jones, Amy
AU - Kainthla, Radhika
AU - Kazmi, Syed M.
N1 - Publisher Copyright:
© 2021 by American Society of Clinical Oncology.
PY - 2021/5/1
Y1 - 2021/5/1
N2 - PURPOSE Young-onset colorectal cancer is an emerging cause of significant morbidity and mortality globally. Despite this, limited data exist regarding clinical characteristics and outcomes, particularly in safety-net populations where access to care is limited. We aimed to study disparities in clinical characteristics and outcomes in patients with young-onset colorectal cancer in the safety-net setting. METHODS We performed a retrospective review of patients,50 years old diagnosed and/or treated for colorectal cancer between 2001 and 2017 at a safety-net hospital. Kaplan-Meier and Cox regression models were constructed to compare overall survival (OS), progression-free survival (PFS), and relapse-free survival (RFS) by race and ethnicity, stratifying for relevant clinical and pathologic factors. RESULTS A total of 395 young-onset patients diagnosed at a safety-net hospital were identified and 270 were included in the analysis (49.6% Hispanic, 25.9% non-Hispanic Black, 20.0% non-Hispanic White, and 4.4% other). Non-Hispanic White race was independently associated with worse OS (hazzard ratio [HR], 0.53; 95% CI, 0.29 to 0.97), as were lack of insurance, higher clinical stage, and mismatch repair proficiency. There was no significant difference seen in PFS or RFS between racial and ethnic groups. CONCLUSION Non-Hispanic White race or ethnicity was found to be independently associated with worse OS in a safety-net population of patients with young-onset colorectal cancer. Other independent predictors of worse OS include higher stage, lack of insurance, and mismatch repair proficiency.
AB - PURPOSE Young-onset colorectal cancer is an emerging cause of significant morbidity and mortality globally. Despite this, limited data exist regarding clinical characteristics and outcomes, particularly in safety-net populations where access to care is limited. We aimed to study disparities in clinical characteristics and outcomes in patients with young-onset colorectal cancer in the safety-net setting. METHODS We performed a retrospective review of patients,50 years old diagnosed and/or treated for colorectal cancer between 2001 and 2017 at a safety-net hospital. Kaplan-Meier and Cox regression models were constructed to compare overall survival (OS), progression-free survival (PFS), and relapse-free survival (RFS) by race and ethnicity, stratifying for relevant clinical and pathologic factors. RESULTS A total of 395 young-onset patients diagnosed at a safety-net hospital were identified and 270 were included in the analysis (49.6% Hispanic, 25.9% non-Hispanic Black, 20.0% non-Hispanic White, and 4.4% other). Non-Hispanic White race was independently associated with worse OS (hazzard ratio [HR], 0.53; 95% CI, 0.29 to 0.97), as were lack of insurance, higher clinical stage, and mismatch repair proficiency. There was no significant difference seen in PFS or RFS between racial and ethnic groups. CONCLUSION Non-Hispanic White race or ethnicity was found to be independently associated with worse OS in a safety-net population of patients with young-onset colorectal cancer. Other independent predictors of worse OS include higher stage, lack of insurance, and mismatch repair proficiency.
UR - http://www.scopus.com/inward/record.url?scp=85106540596&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85106540596&partnerID=8YFLogxK
U2 - 10.1200/OP.20.00777
DO - 10.1200/OP.20.00777
M3 - Article
C2 - 33428470
AN - SCOPUS:85106540596
SN - 2688-1527
VL - 17
SP - E614-E622
JO - JCO Oncology Practice
JF - JCO Oncology Practice
IS - 5
ER -